Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03GAI
|
||||
Former ID |
DIB000108
|
||||
Drug Name |
IR-103
|
||||
Synonyms |
HIV vaccine + Amplivax, IRC; HIV vaccine + Amplivax, Immune Response Corp; HIV vaccine + HYB-2055, IRC; HIV vaccine + HYB-2055, Immune Response Corp; Vaccine (HIV) + Amplivax, IRC; Vaccine (HIV) + Amplivax, Immune Response Corp; Vaccine (HIV) + HYB-2055, IRC; Vaccine (HIV) + HYB-2055, Immune Response Corp
|
||||
Drug Type |
Vaccine
|
||||
Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Discontinued in Phase 3 | [547777] | ||
Company |
Immune Response BioPharma Inc
|
||||
Target and Pathway | |||||
Target(s) | Toll-like receptor 9 | Target Info | [543477] | ||
NetPath Pathway | BCR Signaling Pathway | ||||
PANTHER Pathway | Toll receptor signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.